NO973198L - Aryl- og heteroarylpurinforbindelser - Google Patents
Aryl- og heteroarylpurinforbindelserInfo
- Publication number
- NO973198L NO973198L NO973198A NO973198A NO973198L NO 973198 L NO973198 L NO 973198L NO 973198 A NO973198 A NO 973198A NO 973198 A NO973198 A NO 973198A NO 973198 L NO973198 L NO 973198L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- alkoxy
- halogen
- ring
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Nye bicykliske, kondenserte pyrimidinforbindelser som har den generelle formel (I) (I) hvor X er -CH2-, -NH-(CH2)n-, -0-(CH2)n- eller -S-(CH2)n- hvor n er 0 eller 1; A er en 4,5-kondensert imidazolring N-substituert med R3 som er hydrogen, C1-C4 alkyl eller benzyl, eller A er en 2,3-kondensert pyridinring C-substituert med R4 som er hydrogen, C1-C4 alkyl, C1-C4 alkoksy, halogen eller NRsR^ hvor hver av R5 og R^ uavhengig er H eller C1-C4 alkyl; B er en bicyklisk ring valgt fra tetralin, indan og 2-oksindol; hver av Rj og R2 er uavhengig hydrogen, C1-C4 alkyl, halogen, hydroksy, C]-C4 alkoksy, C1-C4 alkoksykarbonyl, niuo, cyano eller CF3; og de farmasøytisk akseptable saltene derav; og hvor, når samtidig, A er pyridin og B er en tetralinring, R4 er H, C1-C4 alkyl, C1-C4 alkoksy eller halogen og X er som definert ovenfor, så er hver av Rj og R2 forskjellig fra H; og hvor, når samtidig, A er imidazol, X er -NH-(CH2)n- som definert ovenfor, og B er en indanring usubstituert eller substi- tuert med en eller flere av halogen, hydroksy, C1-C4 alkoksy og nitro, så er R3 for- skjellig fra C]-C4 alkyl eller benzyl.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523242.7A GB9523242D0 (en) | 1995-11-14 | 1995-11-14 | Aryl and heteroaryl purine compounds |
| GBGB9524131.1A GB9524131D0 (en) | 1995-11-24 | 1995-11-24 | Pyrido-pyrimidine compounds as tyrosine kinase inhibitors |
| PCT/EP1996/004460 WO1997018212A1 (en) | 1995-11-14 | 1996-10-14 | Aryl and heteroaryl purine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973198D0 NO973198D0 (no) | 1997-07-09 |
| NO973198L true NO973198L (no) | 1997-07-09 |
Family
ID=26308112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973198A NO973198L (no) | 1995-11-14 | 1997-07-09 | Aryl- og heteroarylpurinforbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5965563A (no) |
| EP (1) | EP0802914B1 (no) |
| JP (1) | JPH10512896A (no) |
| CN (1) | CN1168138A (no) |
| AR (1) | AR004320A1 (no) |
| AT (1) | ATE201873T1 (no) |
| AU (1) | AU7292096A (no) |
| BR (1) | BR9607089A (no) |
| CA (1) | CA2209598C (no) |
| DE (1) | DE69613211T2 (no) |
| EA (1) | EA000072B1 (no) |
| ES (1) | ES2159760T3 (no) |
| HU (1) | HUP9801177A3 (no) |
| IL (1) | IL121090A0 (no) |
| NO (1) | NO973198L (no) |
| PL (1) | PL321296A1 (no) |
| WO (1) | WO1997018212A1 (no) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| TW321649B (no) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| GB9424233D0 (en) * | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| DE69613367T2 (de) * | 1995-04-27 | 2002-04-18 | Astrazeneca Ab | Chinazolin derivate |
| GB9508565D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
| GB9508535D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
| GB9508537D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| EP0880508B1 (en) | 1996-02-13 | 2003-04-16 | AstraZeneca AB | Quinazoline derivatives as vegf inhibitors |
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| ATE211134T1 (de) | 1996-03-05 | 2002-01-15 | 4-anilinochinazolin derivate | |
| RO121900B1 (ro) | 1996-04-12 | 2008-07-30 | Warner-Lambert Company | Compuşi inhibitori, ireversibili, ai tirozin kinazelor, compoziţie farmaceutică care îi conţine şi utilizarea acestora |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| AU744986B2 (en) * | 1997-07-12 | 2002-03-07 | Cancer Research Technology Limited | Cyclin dependent kinase inhibiting purine derivatives |
| RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| PA8474101A1 (es) | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| EA005852B1 (ru) | 1998-06-19 | 2005-06-30 | Пфайзер Продактс Инк. | ПИРРОЛО[2,3-d]ПИРИМИДИНЫ |
| WO2001004111A1 (en) | 1999-07-09 | 2001-01-18 | Glaxo Group Limited | Anilinoquinazolines as protein tyrosine kinase inhibitors |
| US6933299B1 (en) | 1999-07-09 | 2005-08-23 | Smithkline Beecham Corporation | Anilinoquinazolines as protein tyrosine kinase inhibitors |
| MXPA02004366A (es) | 1999-11-05 | 2002-11-07 | Astrazeneca Ab | Derivados de quinazolina como inhibidores vegf. |
| CN1195755C (zh) | 1999-12-10 | 2005-04-06 | 辉瑞产品公司 | 吡咯并[2,3－d]嘧啶化合物 |
| MXPA03000068A (es) | 2000-06-26 | 2003-09-25 | Pfizer Prod Inc | Compuestos de pirrolo (2,3-d)pirimidina como agentes inmunosupresores. |
| US7301023B2 (en) | 2001-05-31 | 2007-11-27 | Pfizer Inc. | Chiral salt resolution |
| AU2002346729A1 (en) * | 2001-12-20 | 2003-07-09 | Bristol-Myers Squibb Company | Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
| EP1352910A1 (en) * | 2002-04-10 | 2003-10-15 | Grünenthal GmbH | New analogs of nitrobenzylthioinosine |
| PL378246A1 (pl) | 2002-11-26 | 2006-03-20 | Pfizer Products Inc. | Sposób leczenia odrzucania przeszczepu |
| SG145748A1 (en) * | 2003-08-15 | 2008-09-29 | Irm Llc | 6-substituted anilino purines as rtk inhibitors |
| GEP20084439B (en) * | 2004-01-23 | 2008-07-25 | Amgen Inc | Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof |
| EP1711495A2 (en) | 2004-01-23 | 2006-10-18 | Amgen Inc. | Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
| ES2294400T3 (es) * | 2004-06-29 | 2008-04-01 | Grunenthal Gmbh | Nuevos analogos de notrobenciltioinosina. |
| CA2587642C (en) * | 2004-11-30 | 2013-04-09 | Amgen Inc. | Substituted heterocycles and methods of use |
| JO2787B1 (en) | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| ES2395386T3 (es) | 2005-12-21 | 2013-02-12 | Abbott Laboratories | Compuestos antivirales |
| AU2006330924B2 (en) * | 2005-12-21 | 2012-03-15 | Abbvie Inc. | Anti-viral compounds |
| EP2094276A4 (en) * | 2006-12-20 | 2011-01-05 | Abbott Lab | ANTIVIRAL COMPOUNDS |
| US7795254B2 (en) * | 2007-10-29 | 2010-09-14 | Amgen Inc. | Benzomorpholine derivatives and methods of use |
| PT2384326E (pt) | 2008-08-20 | 2014-06-09 | Zoetis Llc | Compostos de pirrolo[2,3-d]pirimidina |
| DE102011111400A1 (de) * | 2011-08-23 | 2013-02-28 | Merck Patent Gmbh | Bicyclische heteroaromatische Verbindungen |
| CN104470931B (zh) | 2012-05-21 | 2016-10-26 | 拜耳医药股份有限公司 | 取代的苯并噻吩并嘧啶 |
| TW201412740A (zh) * | 2012-09-20 | 2014-04-01 | Bayer Pharma AG | 經取代之吡咯并嘧啶胺基苯并噻唑酮 |
| ES2686909B1 (es) | 2017-03-22 | 2019-08-16 | Consejo Superior Investigacion | Compuestos inhibidores de cdc-7 y su uso para el tratamiento de patologias neurologicas |
| FR3066761B1 (fr) * | 2017-05-23 | 2020-10-30 | Centre Nat Rech Scient | Nouveaux composes inhibiteurs des canaux ioniques |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB828522A (en) * | 1956-11-02 | 1960-02-17 | Geigy Ag J R | Purine derivatives and a process for the preparation thereof |
| US3112192A (en) * | 1960-09-19 | 1963-11-26 | Shell Oil Co | Preservation of cut flowers |
| AU575438B2 (en) * | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
| US4751292A (en) * | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
| DE3529497A1 (de) * | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| WO1990009178A1 (en) * | 1989-01-31 | 1990-08-23 | Whitby Research, Inc. | N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| US5034393A (en) * | 1989-07-27 | 1991-07-23 | Dowelanco | Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives |
| DE69230803T2 (de) * | 1991-11-25 | 2000-12-07 | Pfizer | 5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten |
| US5670501A (en) * | 1994-09-01 | 1997-09-23 | Discovery Therapeutics, Inc. | N-substituted 9-alkyladenines |
-
1996
- 1996-10-14 EA EA199700107A patent/EA000072B1/ru not_active IP Right Cessation
- 1996-10-14 JP JP9518527A patent/JPH10512896A/ja not_active Ceased
- 1996-10-14 WO PCT/EP1996/004460 patent/WO1997018212A1/en not_active Application Discontinuation
- 1996-10-14 AT AT96934673T patent/ATE201873T1/de not_active IP Right Cessation
- 1996-10-14 PL PL96321296A patent/PL321296A1/xx unknown
- 1996-10-14 IL IL12109096A patent/IL121090A0/xx unknown
- 1996-10-14 DE DE69613211T patent/DE69613211T2/de not_active Expired - Fee Related
- 1996-10-14 BR BR9607089A patent/BR9607089A/pt not_active Application Discontinuation
- 1996-10-14 US US08/860,717 patent/US5965563A/en not_active Expired - Fee Related
- 1996-10-14 EP EP96934673A patent/EP0802914B1/en not_active Expired - Lifetime
- 1996-10-14 CA CA002209598A patent/CA2209598C/en not_active Expired - Fee Related
- 1996-10-14 CN CN96191448A patent/CN1168138A/zh active Pending
- 1996-10-14 HU HU9801177A patent/HUP9801177A3/hu unknown
- 1996-10-14 ES ES96934673T patent/ES2159760T3/es not_active Expired - Lifetime
- 1996-10-14 AU AU72920/96A patent/AU7292096A/en not_active Abandoned
- 1996-11-13 AR ARP960105153A patent/AR004320A1/es unknown
-
1997
- 1997-07-09 NO NO973198A patent/NO973198L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0802914B1 (en) | 2001-06-06 |
| ES2159760T3 (es) | 2001-10-16 |
| BR9607089A (pt) | 1997-11-11 |
| EA199700107A1 (ru) | 1997-12-30 |
| EP0802914A1 (en) | 1997-10-29 |
| NO973198D0 (no) | 1997-07-09 |
| DE69613211T2 (de) | 2001-11-15 |
| AR004320A1 (es) | 1998-11-04 |
| PL321296A1 (en) | 1997-12-08 |
| MX9705010A (es) | 1997-10-31 |
| HUP9801177A3 (en) | 1998-11-30 |
| JPH10512896A (ja) | 1998-12-08 |
| CA2209598A1 (en) | 1997-05-22 |
| CN1168138A (zh) | 1997-12-17 |
| EA000072B1 (ru) | 1998-06-25 |
| ATE201873T1 (de) | 2001-06-15 |
| HUP9801177A2 (hu) | 1998-09-28 |
| US5965563A (en) | 1999-10-12 |
| CA2209598C (en) | 2005-06-07 |
| IL121090A0 (en) | 1997-11-20 |
| WO1997018212A1 (en) | 1997-05-22 |
| AU7292096A (en) | 1997-06-05 |
| DE69613211D1 (de) | 2001-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973198L (no) | Aryl- og heteroarylpurinforbindelser | |
| CY1117132T1 (el) | Παραγωγο θειαζολιου | |
| CA2160444A1 (en) | Aroyl-piperdine derivatives | |
| LU92113I2 (fr) | Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA) | |
| KR950008512A (ko) | 이미다조피리딘 유도체의 제조방법 | |
| IE41539L (en) | Chroman derivatives. | |
| NO20080917L (no) | Nytt heterocyklidenacetamidderivat | |
| DE69824332D1 (de) | N-Aryl-piperidinderivate und ihre Verwendung als 5-HT1B-Rezeptorliganden | |
| YU19890A (sh) | Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje | |
| AR017189A1 (es) | Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento | |
| EA199801013A1 (ru) | Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов | |
| ES2039221T3 (es) | Procedimiento para producir derivados de piridazinona. | |
| EP1473295A4 (en) | BICYCLIC FUSIONED PYRIMIDINE DERIVATIVES | |
| ATE194982T1 (de) | Benzoxazepin-derivate als cholinesterase- inhibitoren | |
| AR036734A1 (es) | Derivados de 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxilico | |
| IS2282B (is) | Ný lyfefnasambönd með alfa2viðtakavirkni | |
| ATE58902T1 (de) | Penem-derivate. | |
| YU11494A (sh) | Postupak za dobijanje derivata piperazinilkamforsulfonila kao antagonista oksitocina | |
| ATE370140T1 (de) | Kondensierte bicyclische pyrimidinderivate | |
| ATE168686T1 (de) | N,n'-disubstituierte amidderivate | |
| EA199800720A1 (ru) | Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора | |
| DE69626624D1 (de) | Medikamente gegen trhombocytopenie | |
| NO955071L (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
| Fisyuk et al. | N-3-Oxoalkylamides and-Thioamides in the Synthesis of Heterocyclic Compounds. 6. The Effect of Structural Factors on the Regiodirection of Cyclization of Pyridinium Derivatives of N-(3-Oxoalkyl) chloroacetamides. Structure of 1-(4-Hydroxy-4, 6, 6-trimethyl-2-oxo-3-piperidyl) pyridinium Chloride | |
| KR950008511A (ko) | 이미다조피리딘 유도체의 제조방법 |